IPAS770
Concessão de registro em designação
RPI 2838
27/05/2025
Voltar para busca
Dado oficial do INPI
ZytoNova
Sabia que essa marca já está registrada no Brasil?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Registro de marca em vigor (Madri)Tipo: VerbalEscritório: Brasil
Snapshot rápido
ZytoNova
ST13
BR500000501725888Classe
1, 5, 9, 10, 35, 42, 44
Pedido
501725888
Registro
501725888
Andamento no INPI
- Depósito22/09/23
- Publicação07/05/24
- Exame
- Deferimento18/03/25
- Concessão27/05/25
- Vigente17/11/32
Registro concedido em 27/05/2025 e em vigor até 17/11/2032, quando precisa ser renovado.
Proteção válida até:17/11/2032
Última movimentação publicada pelo INPI: 27/05/2025. Atualizamos a cada nova RPI, publicada semanalmente.
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação INPI
Registro de marca em vigor (Madri)
Tipo de processo
Pedido e registro
Eventos registrados
3
Atualização mais recente
27/05/2025
Tipo de marca
Verbal
Classes Nice
1, 5, 9, 10, 35, 42, 44
Data de depósito
22/09/2023
Data de registro
27/05/2025
Data de expiração
17/11/2032
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Natureza
Madri
Produto/Serviço
Escritório responsável
Brasil
Tipo de titular
NÃO RESIDENTE
Localização do titular
DE
Titulares e representantes
Titulares
ZytoVision GmbH
Representantes
Sem dados de representantes.
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industry and sciencechemicals, biochemicals, for use in the following fields: pathology, genetics, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology, laboratory medicinechemicals and biochemicals for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteinsnucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
Classe 5
Pharmaceuticals and medical preparationsmedical preparations for diagnosticsmedical preparations for in-vitro diagnosticspharmaceuticals, pharmaceutical preparations, medical products, medical preparations, chemical products, chemical preparations, biochemical products, biochemical preparations for medical usepharmaceutical, medicated, chemical and biochemicals and preparations for medical purposes for histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry services and isolation of biomolecules including dna, rna and proteinsnucleic acids (including dna, rna, oligonucleotides, polynucleotides, marked nucleic acids and modified nucleic acids), proteins (including peptides, recombinant proteins and marked proteins), antibodies, dna probes being biochemical substances, rna probes being biochemical substances, oligonucleotide probes being biochemical substances, cells, tissue, tissue sections, and nucleic acids, proteins and cells immobilised on carriers
Classe 9
Scientific research and laboratory apparatus, educational apparatus and simulatorsanalysis apparatus for conducting and evaluating histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including dna, rna and proteinsresearch laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids, analysis apparatus for research laboratories for measuring, testing and examining tissue, cells and biomolecules including dna, rna and proteins
Classe 10
Medical apparatus and instrumentsmedical instrumentsmedical analytical apparatus for medical purposesautomatic analyzers for medical diagnosisphysical analyzers for medical usegenetic testing apparatus for medical purposes
Classe 35
Business management consultancy and advisory servicesoperation of businesses [for others]running of a holding company, namely business management, business administration, office functionsholding company services, namely marketing strategy, professional business and organisational consultancy and management of the business interests of others and legally independent companiesbusiness management and organization consultancyadvisory services for business managementbusiness administrationoffice functionsplanning and monitoring of business developments with regard to organisational matters
Classe 42
Scientific and technology servicesmedical laboratory servicesmedical research laboratory servicesdevelopment of pharmaceutical preparations and medicinesclinical researchresearch relating to biotechnologyscientific consultancy servicesbiological analysis, biochemical analysis, chemical analysis, scientific analysisscientific research in the field of genetics and genetic engineering
Classe 44
Medical servicesmedical diagnostic servicesin vitro analysis for medical and pharmaceutical usemedical services using the knowledge in the field of pathology, genetic science, human genetics, molecular pathologies, molecular biology, microbiology, biotechnology and laboratory medicinemedical services by means of histology, cytology, immunohistology, immunohistochemistry, in situ hybridisation, pcr (polymerase chain reaction), ngs (next generation sequencing), microarray hybridisation (genetic chip or biochip hybridisation), flow cytometry and isolation of biomolecules including dna, rna and proteinsmedical counselingpharmaceutical servicespharmaceutical advicemedical and health services relating to dna, genetics and genetic testingpathology servicesgenetic testing for medical purposes
Publicações
Histórico de despachos e eventos da marca no INPI.
3 publicações encontradas
IPAS768
Deferimento de designação
RPI 2828
18/03/2025
IPAS756
Publicação de pedido de registro para oposição (exame formal de designação concluído)
RPI 2783
07/05/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ZytoNova ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o INPI por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.